Insights on Healthcare And Aging In AmericaView all
West Health Mosaic
A new digital platform offering advanced research capabilities, data visualizations, and key insights and analyses on the impact of healthcare costs, practices, and policies on aging in America.
Explore moreLearn more about MPAs and how to get involved
States across the country are implementing Multisector Plans for Aging to support and prepare for their growing older adult populations.
Your Top Source for MPA Tools and Insights
Through cross-sector collaboration and stakeholder input, MPAs are paving the way for healthy aging. Learn how:
Kansas vs. California: How Does Your State Compare?
Explore the share of population by age in 2023 and uncover key demographic differences between Kansas and California.
Interactive Data Mosaics
View all
Regardless of Political Party, Americans Overwhelmingly Support Medicare Drug Price Negotiations
February 26, 2025
As the pharmaceutical industry ramps up efforts to fight the U.S. government’s historic Medicare Drug Price Negotiation Program, a new West Health-Gallup public opinion survey shows overwhelming bipartisan support for the program, which is forecast to save $100 billion in its first decade.Testing a list of items:Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris ullamcorper scelerisqu...
Trends in HIV Preexposure Prophylaxis Utilization and Spending Among Individuals with Commercial Insurance
February 26, 2025
AbstractIn a cross-sectional analysis of HIV preexposure prophylaxis (PrEP) utilization by commercially insured patients from 2019 to 2021, most prescriptions were for branded formulations of PrEP despite the availability of a generic version. Accounting for the modest relative clinical benefit of branded TAF/FTC (tenofovir alafenamide fumarate/emtricitabine) PrEP over generic TDF/FTC (tenofovir d...
60% of U.S. adults report need for affordable health and social supports and services to help residents remain living independently.
Source: West Health-Gallup Survey on Living Independently, June 3-18, 2024
Public Statements
View all
Trends in HIV Preexposure Prophylaxis Utilization and Spending Among Individuals with Commercial Insurance
October 31, 2024
AbstractIn a cross-sectional analysis of HIV preexposure prophylaxis (PrEP) utilization by commercially insured patients from 2019 to 2021, most prescriptions were for branded formulations of PrEP despite the availability of a generic version. Accounting for the modest relative clinical benefit of branded TAF/FTC (tenofovir alafenamide fumarate/emtricitabine) PrEP over generic TDF/FTC (tenofovir d...